Insiders / Bvf Partners L P/IL
Bvf Partners L P/IL
CIK 1055947personinsiderfund
Companies
6
First seen
Jan 30, 2026
Last activity
Jun 26, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| XOMA Royalty Corp · XOMA | 1,184,000 | — |
| Kymera Therapeutics, Inc. · KYMR | 318,910 | — |
| Repare Therapeutics Inc. · RPTX | 0 | — |
| Immunic, Inc. · IMUX | — | — |
| MoonLake Immunotherapeutics · MLTX | — | — |
| Olema Pharmaceuticals, Inc. · OLMA | — | — |
All securities held
6 positions · latest reported per filing
| Company | Security | Shares |
|---|---|---|
| Kymera Therapeutics, Inc. | Common Stock, $0.0001 par value | 318,910 |
| Kymera Therapeutics, Inc. | Stock Option (Right to Buy)Derivative | 6,068 |
| MoonLake Immunotherapeutics | Class A Ordinary Shares, $0.0001 par value | 1,039,238 |
| MoonLake Immunotherapeutics | Option to BuyDerivative | 22,195 |
| Olema Pharmaceuticals, Inc. | Stock Option (Right to buy)Derivative | 29,500 |
| XOMA Royalty Corp | Common Stock, $0.0075 par value per share | 1,184,000 |
Activity
InsidersInstitutions
This person's insider trades (Form 4), across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jun 26, 2026 | Sell | KYMR Kymera Therapeutics, Inc. Common Stock, $0.0001 par value | $89.24M | -838K -29.94% | 1,960,881 2.36% of shares | high |
| Jun 26, 2026 | Sell | KYMR Kymera Therapeutics, Inc. Common Stock, $0.0001 par value | $66.84M | -628K -28.27% | 1,592,261 1.91% of shares | high |
| Mar 31, 2026 | Sell | MLTX MoonLake Immunotherapeutics Class A Ordinary Shares, $0.0001 par value | $32.44M | -1.9M -18.88% | 8,302,735 9.76% of shares | high |
| Mar 31, 2026 | Sell | MLTX MoonLake Immunotherapeutics Class A Ordinary Shares, $0.0001 par value | $26.35M | -1.6M -19.21% | 6,599,722 7.75% of shares | high |
| Jun 26, 2026 | Sell | KYMR Kymera Therapeutics, Inc. Common Stock, $0.0001 par value | $12.07M | -113K -32.06% | 240,123 0.29% of shares | high |
| May 14, 2026 | Other | XOMA XOMA Royalty Corp Common Stock, $0.0075 par value per share | $9.32M | +2.3M +174.86% | 3,635,758 28.99% of shares | low |
| May 14, 2026 | Other | XOMA XOMA Royalty Corp Common Stock, $0.0075 par value per share | $6.07M | +1.5M +118.81% | 2,773,545 22.12% of shares | low |
| Jun 26, 2026 | Sell | KYMR Kymera Therapeutics, Inc. Common Stock, $0.0001 par value | $5.52M | -52K -39.69% | 78,787 0.09% of shares | medium |
| Mar 31, 2026 | Sell | MLTX MoonLake Immunotherapeutics Class A Ordinary Shares, $0.0001 par value | $4.17M | -249K -19.30% | 1,039,238 1.22% of shares | medium |
| May 14, 2026 | Other | XOMA XOMA Royalty Corp Common Stock, $0.0075 par value per share | $3.11M | +772K | 772,000 6.16% of shares | low |